News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ambion, Inc.'s Former CEO And Founder Launches Asuragen, Inc.


3/14/2006 1:48:55 PM

AUSTIN, Texas--(BUSINESS WIRE)--March 14, 2006--The completion of the $273M sale of Ambion's Research Products Division to Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, resulted in the simultaneous spin-off of Asuragen, Inc. Asuragen is a newly formed molecular diagnostic company led by Matt Winkler, founder and former CEO of Ambion, Inc.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES